Company Profile
| Name | Radena Sciences, Inc. |
| Address | Nihonbashi-Mizuno Building 7F, 1-11-12, Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-0022, Japan |
| Foundation | March 2023 |
| CEO | Satoshi Nagamine |
| Business | Research and development of pharmaceuticals, medical devices and regenerative medicines, and related operations |
Main members
Satoshi Nagamine
Founder and CEO
MD (Kyoto University)
PhD (medicine, Tsukuba University)
MBA (Globis University)
Fellow of the Japanese Society of Neurology
Fellow of the Japanese Society of Internal Medicine
Dr. Nagamine is a neurologist and had been engaged in drug development in Astellas Pharma Inc. and Biogen Japan Ltd, before he founded Radena Sciences, Inc.
He used to be a medical reviewer in Pharmaceuticals and Medical Devices Agency (PMDA), Japanese regulatory authority. He had also worked in Department of Neurology in Tokyo Metropolitan Neurological Hospital as a clinical neurologist and in National Institute of Neurology, National Center of Neurology and Psychiatry as a postdoctoral researcher.
Masayuki Nakamori
Chief Scientific Officer
MD (University of Osaka)
PhD (medicine, University of Osaka)
Fellow and Attending Doctor of the Japanese Society of Neurology
Fellow of the Japanese Society of Internal Medicine
Certified doctor of the Japanese Board of Medical genetics and genomics, Clinical Genetics
Prof. Nakamori is a professor of Department of Neurology in Faculty of Medicine and Health Sciences, Yamaguchi University.
He has been engaged in research of pathological mechanism and treatment of Repeat Expansion Diseases in University of Osaka and University of Rochester.
He enriched his expertise as a neurologist in University of Osaka Hospital, JCHO Osaka Hospital, and Osaka Toneyama Medical Center.